23andMe is grappling with a significant decline following a major data breach and financial struggles. The company, which once boasted a $6 billion valuation, has seen its worth drop over 99% since its public debut in 2021. With around 15 million customers, fears are mounting about the future of their genetic data. CEO Anne Wojcicki is contemplating taking the company private amid investor concerns, leading to the resignation of all independent board members. Privacy advocates are urging users to delete their accounts to protect their data, as the company's privacy policies remain ambiguous about data handling during potential sales.